The global HIV drugs market exceeded a value of US$ 17 Billion in 2017.
One of the primary factors catalysing the growth of the global HIV drugs market is increase in the prevalence of HIV and its diagnosis. Apart from this, the market is also influenced by a rise in the number of government initiatives for spreading the awareness amongst people regarding causes, symptoms and treatments.
Moreover, the introduction of generic drugs, which are cost-effective and chemically identical to branded drugs, act as another factor that is contributing towards the demand for HIV drugs.
Looking forward, the market value is projected to reach approximately US$ 21 Billion by 2023, expanding at a CAGR of more than 3% during 2018-2023.
Market Summary:
Based on class, the market has been segmented into multi-class combination products, nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, protease inhibitors, fusion inhibitors, entry inhibitors - CCR5 co-receptor antagonist and HIV integrase strand transfer inhibitors.
On the basis of distribution channel, the market is segregated as hospital pharmacies, retail pharmacies, online pharmacies and others. Hospital pharmacies currently account for the largest share.
The competitive landscape of the market has also been examined with some of the key players being
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2024. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with...
Although gun violence is down by 12%, gun-related homicide is up by 44%. Therefore, the City of Lauderhill is announcing a pivotal strategy to reduce gun violence and promote peace among its 75,000 residents. This plan highlights Lauderhill's...
Specsavers was recognized in Canada's Best Workplacestm List for 2024 by Great Place To Work®, the global authority on workplace culture. The Company is proud to rank as the highest optical retailer in the medium-sized company category after entering...
St. Joseph's Hospital today announced that it becomes the first health care facility to use checkout-free technology in a hospital cafeteria, demonstrating BayCare and St. Joseph's Hospital's commitment to innovation, patient care and team member...
Veterans with Wounded Warrior Project® (WWP) kicked off the organization's annual Soldier Ride® in the nation's capital with First Lady Jill Biden at the White House today. As part of her Joining Forces initiative to support military and veteran...
Tiger Aesthetics Medical, LLC today announced its acquisition of substantially all of the assets associated with the Sientra Inc. breast implant business. This strategic acquisition will complement Tiger Aesthetics' upcoming adipose cell and tissue...